Ensysce Biosciences Announces Strategic Partnership for the Development and Commercial Launch of PF614 and PF614-MPAR

ENSC Stock  USD 8.62  0.53  5.79%   
About 58% of Ensysce Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Ensysce Biosciences suggests that many traders are alarmed. The current market sentiment, together with Ensysce Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Ensysce Biosciences stock news signals to limit their universe of possible portfolio assets.
  
10 Million Commitment from Specialty Drug Manufacturer to Support Commercialization Efforts SAN DIEGO, CA ACCESSWIRE December 4, 2024 Ensysce Biosciences, Inc. , a clinical-stage pharmaceutical company ...

Read at finance.yahoo.com
Yahoo News
  

Ensysce Biosciences Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Ensysce Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Ensysce Biosciences Fundamental Analysis

We analyze Ensysce Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ensysce Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ensysce Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Sales

Price To Sales Comparative Analysis

Ensysce Biosciences is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Ensysce Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ensysce Biosciences stock to make a market-neutral strategy. Peer analysis of Ensysce Biosciences could also be used in its relative valuation, which is a method of valuing Ensysce Biosciences by comparing valuation metrics with similar companies.

Peers

Ensysce Biosciences Related Equities

VRAXVirax Biolabs   27.98   
0%
100.0%
SONNSonnet Biotherapeutics   8.57   
0%
30.0%
KPRXKiora Pharmaceuticals   7.44   
0%
26.0%
BDRXBiodexa Pharmaceticals   1.11   
3.0%
0%
REVBRevelation Biosciences   1.54   
5.0%
0%
ZURAZura Bio   3.10   
11.0%
0%
CDIOCardio Diagnostics   3.12   
11.0%
0%
ALLRAllarity Therapeutics   3.77   
13.0%
0%
QNRXQuoin Pharmaceuticals   4.29   
15.0%
0%
PHIOPhio Pharmaceuticals   6.60   
23.0%
0%
ATNF180 Life   8.14   
29.0%
0%

Complementary Tools for Ensysce Stock analysis

When running Ensysce Biosciences' price analysis, check to measure Ensysce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ensysce Biosciences is operating at the current time. Most of Ensysce Biosciences' value examination focuses on studying past and present price action to predict the probability of Ensysce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ensysce Biosciences' price. Additionally, you may evaluate how the addition of Ensysce Biosciences to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Stocks Directory
Find actively traded stocks across global markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Technical Analysis
Check basic technical indicators and analysis based on most latest market data